Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/16/25 16:42 | 3/7/25 | ELAN | Health | Drug | Pharmaceutical Preparations | Kurzius Lawrence Erik | IN | D | 2 | P.m | 424 | 14.13 | 0 | 30 | 29 | 132 | D | |||||||||||||||
12/15/25 16:43 | 12/11/25 | ELAN | Health | Drug | Pharmaceutical Preparations | Modi Rajeev A. | IN | O | SEE REMA | 1 | P | 96 | 21.33 | 0 | 5 | 4 | 123 | D | ||||||||||||||
12/15/25 16:42 | 12/11/25 | ELAN | Health | Drug | Pharmaceutical Preparations | Vanhimbergen Robert M | IN | O | EVP,CFO | 1 | P | 150 | 21.64 | 0 | 7 | 6 | 124 | D | ||||||||||||||
12/15/25 16:41 | 12/11/25 | ELAN | Health | Drug | Pharmaceutical Preparations | Simmons Jeffrey N | IN | DO | P,CEO,Di | 2 | P | 1,779 | 14.58 | 0 | 122 | 7 | 1,969 | I | ||||||||||||||
3/7/25 16:21 | 3/5/25 | ELAN | Health | Drug | Pharmaceutical Preparations | Hoover R David | IN | D | 1 | P | 273 | 10.90 | 0 | 25 | 8 | 322 | I | |||||||||||||||
8/26/24 17:05 | 8/22/24 | ELAN | Health | Drug | Pharmaceutical Preparations | Harrington Michael J | IN | D | 1 | P | 52 | 14.85 | 0 | 4 | 5 | 81 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |